Clinical Trial Update: Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.

View source ↗

Summary

A clinical trial update for Tulane iPredict, Prevent Study evaluating the progression of atrial myopathy in patients with atrial fibrillation. Recruitment is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Tulane University School of Medicine | Conditions: Atrial Fibrillation | Status: RECRUITING